Will AR Devices Be Able to Replace Phones?

On Spatial Perspectives, host Dan Cui will have a one-on-one dialog with innovators and thought leaders in the growing Spatial Reality, or Spatial Computing, market. Cui will invite guests who can discuss the real world use cases of the technology and how it could benefit mankind while exploring any drawbacks and how they might be mitigated.

 

Augmented reality (AR) is buzzing, with more demand and opportunities, accelerated partly by a closed world. While smart glasses aren’t new, adoption has been low, due more to the fact they just weren’t wearable. On today’s episode, host Dan Cui welcomed former colleague and friend, Paul Travers, a veteran in the space and CEO and Founder of Vuzix.

Cui took viewers way back to the beginnings of virtual reality (VR) with one of Traver’s first innovations, the first consumer VR headset comparing it to what available now. He said, “It got much smaller over time. The technology had a long way to go, and use cases have exploded for VR.”

The company’s next-generation smart glass has all the features and functions of any AR product. What makes it unique is its wearability.

Travers noted, “They are AR devices that allow you to work in the real world and access information you’d need from a tablet, but it’s all hands-free.”

They also use Waveguide optics and work like a phone and computer. The company picked up three CES (Consumer Electronics Show) awards this year for the product.

The glasses are filling the gap at a time when being there in person isn’t possible. “They work as remote support for the medical field, technicians, and others. It’s really the future of computing,” Travers added.

On the consumer side, Travers sees the glasses as possible a movement toward keeping “phones in your pocket.” With plug and play apps, users can look at a restaurant through the glasses and see their Yelp reviews. They can record a baseball game while actually watching it. Travers also shared the Smart Swim application that automates workouts, measures activity, and more.

Listen to Previous Episodes of Spatial Perspectives Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More